These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3776539)

  • 21. Mechanism of vasoselective action of mebudipine, a new calcium channel blocker.
    Mirkhani H; Dirin M; Youssef-Zayeh I
    Vascul Pharmacol; 2004 Aug; 42(1):23-9. PubMed ID: 15664884
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effects of 2-[(diethylamino)acetyl]-1,2,3,4-tetrahydro-6, 7-dimethoxyl-1-[1'-(6"-methoxy-2"-naphthalenyl)ethyl]-isoquinoline on isolated guinea pig papillary muscle and heart atrium.
    Wu GT; Dong H; Liang ZJ
    Zhongguo Yao Li Xue Bao; 1995 May; 16(3):239-42. PubMed ID: 7660819
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Separation of the coronary vasodilator from the cardiac effects of PN 200-110, a new dihydropyridine calcium antagonist, in the dog heart.
    Wada Y; Satoh K; Taira N
    J Cardiovasc Pharmacol; 1985; 7(1):190-6. PubMed ID: 2580142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Calcium-blockers or calcium antagonists].
    Chávez Rivera I
    Arch Inst Cardiol Mex; 1982; 52(3):259-67. PubMed ID: 7052003
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effects of nicardipine hydrochloride on hemodynamics and regional myocardial functions in experimental coronary ischemia].
    Bando S; Kakutani A; Shinomiya H; Noda T; Minezono K; Mori H
    Kokyu To Junkan; 1983 Aug; 31(8):875-80. PubMed ID: 6658218
    [No Abstract]   [Full Text] [Related]  

  • 26. [Effects of magnesium and nicardipine in the cardioplegic solution on the coronary arteries and myocardium].
    Shikano K; Nasu M; Miyamura K; Sakai T; Shomura S
    Rinsho Kyobu Geka; 1984 Sep; 4(5):556-60. PubMed ID: 6522980
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of L-type calcium channel blockade by nifedipine and/or cadmium in guinea pig ventricular myocytes.
    Shen JB; Jiang B; Pappano AJ
    J Pharmacol Exp Ther; 2000 Aug; 294(2):562-70. PubMed ID: 10900233
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fundamental cardiac and vascular effects of Ca++-antagonistic coronary drugs].
    Fleckenstein A
    Med Klin; 1975 Oct; 70(42):1665-74. PubMed ID: 1102892
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute dilatory and negative inotropic effects of homocysteine are inhibited by an adenosine blocker.
    Kennedy RH; Owings R; Joseph J; Melchert RB; Hauer-Jensen M; Boerma M
    Clin Exp Pharmacol Physiol; 2006 Apr; 33(4):340-4. PubMed ID: 16620298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasodilatory action of HA1004 [N-(2-guanidinoethyl)-5-isoquinolinesulfonamide], a novel calcium antagonist with no effect on cardiac function.
    Asano T; Hidaka H
    J Pharmacol Exp Ther; 1984 Oct; 231(1):141-5. PubMed ID: 6436469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiapamil, a new calcium antagonist. 1. Demonstration of calcium antagonistic activity and related studies.
    Eigenmann R; Blaber L; Nakamura K; Thorens S; Haeusler G
    Arzneimittelforschung; 1981; 31(9):1393-401. PubMed ID: 7197945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A pharmacological investigation on a possible calcium antagonistic action of propranolol.
    Rokutanda M; Araki S; Sakanashi M
    Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):99-108. PubMed ID: 6870391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
    Hondeghem LM; Ayad MJ; Robertson RM
    J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on tetrandrine calcium antagonistic action.
    Fang DC; Jiang MX
    Chin Med J (Engl); 1986 Aug; 99(8):638-44. PubMed ID: 3100217
    [No Abstract]   [Full Text] [Related]  

  • 35. [Negative inotropic effects and constipation caused by verapamil?].
    Joost HG; Müller A
    Dtsch Med Wochenschr; 2000 Apr; 125 Suppl 1():S5. PubMed ID: 10818993
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative evaluation of the vasodilator effect of verapamil, nifedipine and diltiazem on isolated perfused coronary arteries of rabbit.
    Kaur AH; Singh M; Singh J
    Indian J Physiol Pharmacol; 1984; 28(3):206-10. PubMed ID: 6519762
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Action of dihydropyridine Ca-channel-modulators on isolated heart preparations.
    Thomas G; Schramm M; Metzger G; Bechem M
    Cardiologia; 1987 Sep; 32(9):1047-52. PubMed ID: 2446763
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of calcium antagonist darodipine on the isolated human heart.
    Ginsburg R; Carey B; Zera P
    Eur J Pharmacol; 1986 Jun; 125(2):287-91. PubMed ID: 3743638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Verapamil: a selective antagonist of constrictor substances in dog coronary artery: implications for variant angina.
    Angus JA; Brazenor RM; Le Duc MA
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():15-28. PubMed ID: 6956474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of binding of the Ca++ channel antagonist, [3H]nitrendipine, to guinea-pig ileal smooth muscle.
    Bolger GT; Gengo P; Klockowski R; Luchowski E; Siegel H; Janis RA; Triggle AM; Triggle DJ
    J Pharmacol Exp Ther; 1983 May; 225(2):291-309. PubMed ID: 6842393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.